Polaris Venture Management Co. V, L.L.C. - SELECTA BIOSCIENCES INC ownership

SELECTA BIOSCIENCES INC's ticker is SELB and the CUSIP is 816212104. A total of 97 filers reported holding SELECTA BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is 1.89 and the average weighting 0.2%.

Quarter-by-quarter ownership
Polaris Venture Management Co. V, L.L.C. ownership history of SELECTA BIOSCIENCES INC
ValueSharesWeighting
Q1 2021$12,550,000
+49.3%
2,773,4790.0%16.27%
+48.4%
Q4 2020$8,404,000
+22.2%
2,773,4790.0%10.97%
-3.3%
Q3 2020$6,878,000
-12.7%
2,773,4790.0%11.34%
+85.0%
Q2 2020$7,877,000
+17.8%
2,773,4790.0%6.13%
+1.4%
Q1 2020$6,684,000
+0.5%
2,773,4790.0%6.05%
+25.1%
Q4 2019$6,650,000
+37.0%
2,773,4790.0%4.84%
+75.4%
Q3 2019$4,854,000
-2.2%
2,773,4790.0%2.76%
-29.3%
Q2 2019$4,965,000
-24.5%
2,773,4790.0%3.90%
-29.9%
Q1 2019$6,573,000
+53.8%
2,773,479
+72.6%
5.56%
+21.9%
Q4 2018$4,274,000
-82.9%
1,606,8130.0%4.56%
-63.5%
Q3 2018$24,986,000
+17.4%
1,606,8130.0%12.51%
+7.8%
Q2 2018$21,290,000
+30.0%
1,606,8130.0%11.60%
+24.3%
Q1 2018$16,373,000
+3.9%
1,606,8130.0%9.33%
-32.8%
Q4 2017$15,763,000
-46.9%
1,606,813
-1.3%
13.90%
-45.6%
Q3 2017$29,702,000
-22.3%
1,627,527
-15.4%
25.53%
-35.4%
Q2 2017$38,213,000
+38.7%
1,924,1510.0%39.54%
+34.0%
Q1 2017$27,554,000
-16.5%
1,924,1510.0%29.50%
-24.7%
Q4 2016$32,999,000
+20.4%
1,924,1510.0%39.17%
+35.3%
Q3 2016$27,419,000
+1.9%
1,924,1510.0%28.95%
+0.2%
Q2 2016$26,919,0001,924,15128.90%
Other shareholders
SELECTA BIOSCIENCES INC shareholders Q4 2020
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 1,024,668$4,263,0001.50%
CM Management, LLC 400,000$1,664,0001.24%
Endurant Capital Management LP 1,021,501$4,249,0000.97%
Boxer Capital, LLC 3,284,072$13,662,0000.48%
IRONWOOD INVESTMENT MANAGEMENT LLC 192,524$801,0000.42%
Artal Group S.A. 4,000,000$16,640,0000.37%
HALL LAURIE J TRUSTEE 52,775$220,0000.08%
Opaleye Management Inc. 106,000$441,0000.08%
Virtus ETF Advisers LLC 42,433$177,0000.08%
HighVista Strategies LLC 22,269$92,0000.06%
View complete list of SELECTA BIOSCIENCES INC shareholders